- Home
- CAKE vs SLNO Comparison
CAKE vs SLNO Comparison
Compare CAKE & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAKE
- SLNO
- Stock Information
- Founded
- CAKE 1972
- SLNO 1999
- Country
- CAKE United States
- SLNO United States
- Employees
- CAKE N/A
- SLNO N/A
- Industry
- CAKE Restaurants
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CAKE Consumer Discretionary
- SLNO Health Care
- Exchange
- CAKE Nasdaq
- SLNO Nasdaq
- Market Cap
- CAKE 2.8B
- SLNO 3.8B
- IPO Year
- CAKE 1992
- SLNO 2014
- Fundamental
- Price
- CAKE $62.66
- SLNO $83.47
- Analyst Decision
- CAKE Hold
- SLNO Strong Buy
- Analyst Count
- CAKE 14
- SLNO 9
- Target Price
- CAKE $54.07
- SLNO $105.11
- AVG Volume (30 Days)
- CAKE 1.3M
- SLNO 1.5M
- Earning Date
- CAKE 07-29-2025
- SLNO 08-06-2025
- Dividend Yield
- CAKE 1.73%
- SLNO N/A
- EPS Growth
- CAKE 45.67
- SLNO N/A
- EPS
- CAKE 3.19
- SLNO N/A
- Revenue
- CAKE $3,617,673,000.00
- SLNO N/A
- Revenue This Year
- CAKE $7.04
- SLNO N/A
- Revenue Next Year
- CAKE $6.13
- SLNO N/A
- P/E Ratio
- CAKE $19.55
- SLNO N/A
- Revenue Growth
- CAKE 4.42
- SLNO N/A
- 52 Week Low
- CAKE $33.50
- SLNO $41.50
- 52 Week High
- CAKE $65.99
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- CAKE 63.02
- SLNO 51.94
- Support Level
- CAKE $62.87
- SLNO $79.70
- Resistance Level
- CAKE $65.16
- SLNO $90.32
- Average True Range (ATR)
- CAKE 1.61
- SLNO 3.45
- MACD
- CAKE -0.14
- SLNO -0.57
- Stochastic Oscillator
- CAKE 68.67
- SLNO 26.46
About CAKE Cheesecake Factory Incorporated (The)
Cheesecake Factory Inc owns and operates restaurants in the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.